Deconstructing a medication regimen.
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, USA.
D000293:Adolescent; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D001590:Benztropine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D001711:Biotransformation; D001714:Bipolar Disorder / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D008657:Metabolic Clearance Rate; D011899:Ranitidine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D053608:Stupor / Q000097:blood / Q000139:chemically induced*; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D005473:Fluoxetine; D001590:Benztropine; D016651:Lithium Carbonate; D002220:Carbamazepine; D014635:Valproic Acid; D011899:Ranitidine; D018967:Risperidone